NewsBenzingaBio-Rad Laboratories reafirma su orientación de ventas para el ejercicio fiscal 2026 de 2.506 mil millones a 2.596 mil millones de dólares, frente a los 2.588 mil millones estimados Bio-Rad Laboratories reafirma su orientación de ventas para el ejercicio fiscal 2026 de 2.506 mil millones a 2.596 mil millones de dólares, frente a los 2.588 mil millones estimados Benzinga 2026.11.04 21:59 (GMT+0) Open on Benzinga Other news Ramp in Talks to Raise at Least $1 Billion at Valuation of Up to $75 Billion How Everyday Investors Are Playing the Nvidia Drama Curve: Fee Conversion Contract Loses $38.2K in Attack, Disabled With Replacement Planned Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares